Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor.
Curti BD, Koguchi Y, Leidner RS, Rolig AS, Sturgill ER, Sun Z, Wu Y, Rajamanickam V, Bernard B, Hilgart-Martiszus I, Fountain CB, Morris G, Iwamoto N, Shimada T, Chang S, Traber PG, Zomer E, Horton JR, Shlevin H, Redmond WL.
Curti BD, et al.
J Immunother Cancer. 2021 Apr;9(4):e002371. doi: 10.1136/jitc-2021-002371.
J Immunother Cancer. 2021.
PMID: 33837055
Free PMC article.
Clinical Trial.